Motor point chemodenervation or chemical neurolytic procedures require low current stimulation location in the order of 0.2-0.5 mA, depending on the stimulation pulse width.  Pulse width is an essential part of the stimulation delivery.  Narrower pulse widths deliver the current pulse over the duration of the pulse width.  This means that the energy delivered is short for short…

Drop by and Visit Booth #421 Intronix Technologies’ innovative Myoguide EMG guided injection system will be available to play with at the American Association of Neuromuscular & Electrodiagnostic Medicine 2019 AANEM Annual Meeting in Austin, Texas October 16-19, 2019.  We are happy to be joining our friends and distributor, Ambu USA, in their booth #421.  Please drop by and visit us!

TORONTO, May15, 2018 – Chronic pain is a common condition with significant physical, psychological, social, and economic impact. The Institute of Medicine estimates that >100 million Americans suffer from chronic pain. Conservative estimates suggest that well over US $500 billion per year is spent in the treatment of these pain conditions. This is associated with…

Imagine for a moment the many different advances in technology that have helped progress the effectiveness of healthcare over the years. The advent of computers, of laser technology, of the internet and many, many others have all made a significant impact on the quality and performance of healthcare provision, helping healthcare professionals, improving treatment standards…

Intronix Technologies will be there to help out with the hands-on workshops, and answer any questions about Myoguide injection guidance system, and introducing our new patient management software system “Myoguide DOC”! The American Association of Physical Medicine and Rehabilitation Annual Assembly is taking place Colorado Convention Center, in 
Denver, from October 11-15, 2017. Myoguide DOC…

TORONTO, Sept. 6, 2017 /PRNewswire/ — Innovative augmented reality technology aimed at enhancing the delivery of medical simulations, which will assist the treatment of millions of patients suffering from pain and spasticity, will be developed thanks to new strategic collaboration. Medical professionals are expected to continuously acquire new knowledge and skills while treating their patients.…

Myoguide DOC is designed for clinicians managing patients with pain and spasticity.  Clinicians can document patient history, treatment, treatment plans, generate reports, as well as, add and track spasticity, capability, and pain index scores. https://www.intronixtech.com/myoguide-doc-patient-management-software-for-pain-and-spasticity/   Clinicians can mark, as well as, attach details, where they inject using anatomical graphics.  They can also review the complete patient injection history at any…

Come have a look at the first glimpse of Myoguide DOC on our new website page: https://www.intronixtech.com/myoguide-doc-patient-management-software-for-pain-and-spasticity/ Pain And Spasticity Management At A GLANCE! Designed for clinicians managing patients with pain and spasticity.  Clinicians can document patient history, treatment, treatment plans, generate reports,  as well as, add and track spasticity, capability, and pain index scores. Clinicians can mark, as well…

Intronix will be attending the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) meeting in Phoenix, Arizona, September 13-16, 2017. This year’s meeting will be held at the JW Marriott Phoenix Desert Ridge Resort & Spa. We are looking forward to the opportunity to showcase our new patient management software package “Myoguide DOC”. Myoguide DOC…

Intronix has been officially invited to supply Myoguide units for three hands-on workshops at the American Association of Physical Medicine and Rehabilitation. The AAPM&R Annual Assembly is taking place Colorado Convention Center
, in 
Denver, from October 11-15, 2017. We are very pleased and honoured to have the opportunity to continue to support the AAPM&R! This will…

Patient Pain Management at a Glance Myoguide DOC: Saves Time, Increases Productivity, and Improves Communication TORONTO, April 11, 2017 – Intronix Technologies will be launching “Myoguide DOC”, a comprehensive software package designed to help clinicians who inject Botulinum Toxins, such as Botox®, Dysport® and Xeomin® to manage their patient’s spasticity and pain.   Myoguide DOC…